First Trimester Urine and Serum Metabolomics for Prediction of Preeclampsia and Gestational Hypertension: A Prospective Screening Study
Hypertensive disorders of pregnancy, including preeclampsia, are major contributors to maternal morbidity. The goal of this study was to evaluate the potential of metabolomics to predict preeclampsia and gestational hypertension from urine and serum samples in early pregnancy, and elucidate the meta...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2015-09-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/16/9/21520 |
id |
doaj-14fcc3a405ef4953a1ef068e22e05bb7 |
---|---|
record_format |
Article |
spelling |
doaj-14fcc3a405ef4953a1ef068e22e05bb72020-11-25T01:44:04ZengMDPI AGInternational Journal of Molecular Sciences1422-00672015-09-01169215202153810.3390/ijms160921520ijms160921520First Trimester Urine and Serum Metabolomics for Prediction of Preeclampsia and Gestational Hypertension: A Prospective Screening StudyMarie Austdal0Line H. Tangerås1Ragnhild B. Skråstad2Kjell Salvesen3Rigmor Austgulen4Ann-Charlotte Iversen5Tone F. Bathen6Department of Circulation and Medical Imaging, Faculty of Medicine, Norwegian University of Science and Technology, 7491 Trondheim, NorwaySt. Olavs Hospital, Trondheim University Hospital, 7006 Trondheim, NorwayDepartment of Laboratory Medicine Children's and Women's Health, Faculty of Medicine, Norwegian University of Science and Technology, 7491 Trondheim, NorwayNational Center for Fetal Medicine, Department of Obstetrics and Gynecology, St. Olavs Hospital, Trondheim University Hospital, 7030 Trondheim, NorwayCentre of Molecular Inflammation Research, Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, 7491 Trondheim, NorwayCentre of Molecular Inflammation Research, Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, 7491 Trondheim, NorwayDepartment of Circulation and Medical Imaging, Faculty of Medicine, Norwegian University of Science and Technology, 7491 Trondheim, NorwayHypertensive disorders of pregnancy, including preeclampsia, are major contributors to maternal morbidity. The goal of this study was to evaluate the potential of metabolomics to predict preeclampsia and gestational hypertension from urine and serum samples in early pregnancy, and elucidate the metabolic changes related to the diseases. Metabolic profiles were obtained by nuclear magnetic resonance spectroscopy of serum and urine samples from 599 women at medium to high risk of preeclampsia (nulliparous or previous preeclampsia/gestational hypertension). Preeclampsia developed in 26 (4.3%) and gestational hypertension in 21 (3.5%) women. Multivariate analyses of the metabolic profiles were performed to establish prediction models for the hypertensive disorders individually and combined. Urinary metabolomic profiles predicted preeclampsia and gestational hypertension at 51.3% and 40% sensitivity, respectively, at 10% false positive rate, with hippurate as the most important metabolite for the prediction. Serum metabolomic profiles predicted preeclampsia and gestational hypertension at 15% and 33% sensitivity, respectively, with increased lipid levels and an atherogenic lipid profile as most important for the prediction. Combining maternal characteristics with the urinary hippurate/creatinine level improved the prediction rates of preeclampsia in a logistic regression model. The study indicates a potential future role of clinical importance for metabolomic analysis of urine in prediction of preeclampsia.http://www.mdpi.com/1422-0067/16/9/21520NMR spectroscopypreeclampsiametabolomicsPLS-DAgestational hypertensionpredictionfirst-trimester screeningbiomarker |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Marie Austdal Line H. Tangerås Ragnhild B. Skråstad Kjell Salvesen Rigmor Austgulen Ann-Charlotte Iversen Tone F. Bathen |
spellingShingle |
Marie Austdal Line H. Tangerås Ragnhild B. Skråstad Kjell Salvesen Rigmor Austgulen Ann-Charlotte Iversen Tone F. Bathen First Trimester Urine and Serum Metabolomics for Prediction of Preeclampsia and Gestational Hypertension: A Prospective Screening Study International Journal of Molecular Sciences NMR spectroscopy preeclampsia metabolomics PLS-DA gestational hypertension prediction first-trimester screening biomarker |
author_facet |
Marie Austdal Line H. Tangerås Ragnhild B. Skråstad Kjell Salvesen Rigmor Austgulen Ann-Charlotte Iversen Tone F. Bathen |
author_sort |
Marie Austdal |
title |
First Trimester Urine and Serum Metabolomics for Prediction of Preeclampsia and Gestational Hypertension: A Prospective Screening Study |
title_short |
First Trimester Urine and Serum Metabolomics for Prediction of Preeclampsia and Gestational Hypertension: A Prospective Screening Study |
title_full |
First Trimester Urine and Serum Metabolomics for Prediction of Preeclampsia and Gestational Hypertension: A Prospective Screening Study |
title_fullStr |
First Trimester Urine and Serum Metabolomics for Prediction of Preeclampsia and Gestational Hypertension: A Prospective Screening Study |
title_full_unstemmed |
First Trimester Urine and Serum Metabolomics for Prediction of Preeclampsia and Gestational Hypertension: A Prospective Screening Study |
title_sort |
first trimester urine and serum metabolomics for prediction of preeclampsia and gestational hypertension: a prospective screening study |
publisher |
MDPI AG |
series |
International Journal of Molecular Sciences |
issn |
1422-0067 |
publishDate |
2015-09-01 |
description |
Hypertensive disorders of pregnancy, including preeclampsia, are major contributors to maternal morbidity. The goal of this study was to evaluate the potential of metabolomics to predict preeclampsia and gestational hypertension from urine and serum samples in early pregnancy, and elucidate the metabolic changes related to the diseases. Metabolic profiles were obtained by nuclear magnetic resonance spectroscopy of serum and urine samples from 599 women at medium to high risk of preeclampsia (nulliparous or previous preeclampsia/gestational hypertension). Preeclampsia developed in 26 (4.3%) and gestational hypertension in 21 (3.5%) women. Multivariate analyses of the metabolic profiles were performed to establish prediction models for the hypertensive disorders individually and combined. Urinary metabolomic profiles predicted preeclampsia and gestational hypertension at 51.3% and 40% sensitivity, respectively, at 10% false positive rate, with hippurate as the most important metabolite for the prediction. Serum metabolomic profiles predicted preeclampsia and gestational hypertension at 15% and 33% sensitivity, respectively, with increased lipid levels and an atherogenic lipid profile as most important for the prediction. Combining maternal characteristics with the urinary hippurate/creatinine level improved the prediction rates of preeclampsia in a logistic regression model. The study indicates a potential future role of clinical importance for metabolomic analysis of urine in prediction of preeclampsia. |
topic |
NMR spectroscopy preeclampsia metabolomics PLS-DA gestational hypertension prediction first-trimester screening biomarker |
url |
http://www.mdpi.com/1422-0067/16/9/21520 |
work_keys_str_mv |
AT marieaustdal firsttrimesterurineandserummetabolomicsforpredictionofpreeclampsiaandgestationalhypertensionaprospectivescreeningstudy AT linehtangeras firsttrimesterurineandserummetabolomicsforpredictionofpreeclampsiaandgestationalhypertensionaprospectivescreeningstudy AT ragnhildbskrastad firsttrimesterurineandserummetabolomicsforpredictionofpreeclampsiaandgestationalhypertensionaprospectivescreeningstudy AT kjellsalvesen firsttrimesterurineandserummetabolomicsforpredictionofpreeclampsiaandgestationalhypertensionaprospectivescreeningstudy AT rigmoraustgulen firsttrimesterurineandserummetabolomicsforpredictionofpreeclampsiaandgestationalhypertensionaprospectivescreeningstudy AT anncharlotteiversen firsttrimesterurineandserummetabolomicsforpredictionofpreeclampsiaandgestationalhypertensionaprospectivescreeningstudy AT tonefbathen firsttrimesterurineandserummetabolomicsforpredictionofpreeclampsiaandgestationalhypertensionaprospectivescreeningstudy |
_version_ |
1725030151079591936 |